IGC
India Globalization Capital Inc
NYSE MKT: IGC · HEALTHCARE · BIOTECHNOLOGY
$0.32
+3.16% today
Updated 2026-04-30
Market cap
$31.63M
P/E ratio
—
P/S ratio
28.60x
EPS (TTM)
$-0.06
Dividend yield
—
52W range
$0 – $1
Volume
1.2M
WallStSmart proprietary scores
17
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F5.8
Quality
C+2.5
Profitability
F5.0
Valuation
C+3/9
Piotroski F-Score
Weak
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$4.13
+1190.68%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Debt/equity 0.02x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-5.37M
- Revenue declining -53.60% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|
| Revenue | $911000.00 | $1.34M | $1.27M | $869000.00 | $1.11M |
| Net income | $-11.51M | $-13.00M | $-7.12M | $-4.15M | $-4.15M |
| EPS | — | — | — | — | $-0.06 |
| Free cash flow | $-7.67M | $-5.71M | $-5.28M | $-5.37M | $-5.37M |
| Profit margin | -1,263.01% | -966.54% | -560.27% | -477.10% | — |
Peer comparison
Smart narrative
India Globalization Capital Inc trades at $0.32. Our Smart Value Score of 17/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. TTM revenue stands at $1.11M.
Frequently asked questions
What is India Globalization Capital Inc's stock price?
India Globalization Capital Inc (IGC) trades at $0.32.
Is India Globalization Capital Inc overvalued?
Smart Value Score 17/100 (Grade F, Strong Sell).
What is the price target of India Globalization Capital Inc (IGC)?
The analyst target price is $4.13, representing +1190.7% upside from the current price of $0.32.
What is India Globalization Capital Inc's revenue?
TTM revenue is $1.11M.
Piotroski F-Score?
3/9 — weak financial health.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNYSE MKT
CurrencyUSD
Quick metrics
P/S ratio28.60x
ROE-83.30%
Beta0.31
50D MA$0.29
200D MA$0.34
Shares out0.10B
Float0.08B
Short ratio—
Avg volume1.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—